Free Trial

Corteva (CTVA) Financials

Corteva logo
$74.85 +0.39 (+0.52%)
Closing price 06/11/2026 03:59 PM Eastern
Extended Trading
$75.68 +0.83 (+1.11%)
As of 06:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Corteva

Annual Income Statements for Corteva

This table shows Corteva's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-5,065 -959 681 1,759 1,147 735 907 1,094
Consolidated Net Income / (Loss)
-5,027 -941 701 1,769 1,158 747 919 1,105
Net Income / (Loss) Continuing Operations
-6,775 -270 756 1,822 1,216 941 863 1,204
Total Pre-Tax Income
-6,806 -316 675 2,346 1,426 1,093 1,275 1,688
Total Operating Income
-6,637 -382 508 1,028 1,565 1,774 1,808 2,438
Total Gross Profit
4,339 5,271 5,710 6,435 7,019 7,306 7,379 8,229
Total Revenue
14,287 13,846 14,217 15,655 17,455 17,226 16,908 17,401
Operating Revenue
14,287 13,846 14,217 15,655 17,455 17,226 16,908 17,401
Total Cost of Revenue
9,948 8,575 8,507 9,220 10,436 9,920 9,529 9,172
Operating Cost of Revenue
9,948 8,575 8,507 9,220 10,436 9,920 9,529 9,172
Total Operating Expenses
10,976 5,653 5,202 5,407 5,454 5,532 5,571 5,791
Selling, General & Admin Expense
3,041 3,065 3,043 3,209 3,173 3,176 3,196 3,492
Research & Development Expense
1,355 1,147 1,142 1,187 1,216 1,337 1,402 1,474
Amortization Expense
391 475 682 722 702 683 685 644
Other Operating Expenses / (Income)
992 744 0.00 0.00 - 0.00 0.00 35
Restructuring Charge
694 222 335 289 363 336 288 146
Total Other Income / (Expense), net
-169 66 167 1,318 -139 -681 -533 -750
Interest Expense
418 149 45 30 79 233 233 180
Other Income / (Expense), net
249 215 212 1,348 -60 -448 -300 -570
Income Tax Expense
-31 -46 -81 524 210 152 412 484
Net Income / (Loss) Discontinued Operations
1,748 -671 -55 -53 -58 -194 56 -99
Net Income / (Loss) Attributable to Noncontrolling Interest
38 18 20 10 11 12 12 11
Basic Earnings per Share
($6.76) ($1.28) $0.91 $2.39 $1.59 $1.04 $1.31 $1.60
Weighted Average Basic Shares Outstanding
- 749.40M 744.06M 727.02M 712.82M 701.78M 685.56M 672.52M
Diluted Earnings per Share
($6.76) ($1.28) $0.91 $2.37 $1.58 $1.03 $1.30 $1.60
Weighted Average Diluted Shares Outstanding
- 749.40M 744.06M 727.02M 712.82M 701.78M 685.56M 672.52M
Weighted Average Basic & Diluted Shares Outstanding
- 749.40M 744.06M 727.02M 712.82M 701.78M 685.56M 672.52M
Cash Dividends to Common per Share
- $0.26 $0.52 $0.54 - $0.62 $0.66 $0.70

Quarterly Income Statements for Corteva

This table shows Corteva's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-321 -253 419 1,053 -524 -41 652 1,314 -320 -552 720
Consolidated Net Income / (Loss)
-318 -251 423 1,056 -521 -39 656 1,316 -318 -549 723
Net Income / (Loss) Continuing Operations
-315 -231 376 1,056 -519 -50 667 1,382 -308 -537 725
Total Pre-Tax Income
-444 -323 482 1,338 -633 88 784 1,804 -370 -530 858
Total Operating Income
-237 -167 622 1,517 -460 129 805 1,753 -301 181 1,011
Total Gross Profit
944 1,341 1,942 3,194 761 1,482 2,075 3,524 974 1,656 2,533
Total Revenue
2,590 3,707 4,492 6,112 2,326 3,978 4,417 6,456 2,618 3,910 4,905
Operating Revenue
2,590 3,707 4,492 6,112 2,326 3,978 4,417 6,456 2,618 3,910 4,905
Total Cost of Revenue
1,646 2,366 2,550 2,918 1,565 2,496 2,342 2,932 1,644 2,254 2,372
Operating Cost of Revenue
1,646 2,366 2,550 2,918 1,565 2,496 2,342 2,932 1,644 2,254 2,372
Total Operating Expenses
1,181 1,508 1,320 1,677 1,221 1,353 1,270 1,771 1,275 1,475 1,522
Selling, General & Admin Expense
670 735 736 1,054 671 735 751 1,156 725 860 877
Research & Development Expense
335 357 332 357 348 365 335 375 351 413 341
Amortization Expense
174 175 177 174 170 164 162 161 162 159 160
Other Operating Expenses / (Income)
- - - - 0.00 - 0.00 - 7.00 - 52
Restructuring Charge
2.00 241 75 92 32 89 22 79 30 15 92
Total Other Income / (Expense), net
-207 -156 -140 -179 -173 -41 -21 51 -69 -711 -153
Interest Expense
58 62 41 66 66 60 36 52 46 46 36
Other Income / (Expense), net
-149 -94 -99 -113 -107 19 15 103 -23 -665 -117
Income Tax Expense
-129 -92 106 282 -114 138 117 422 -62 7.00 133
Net Income / (Loss) Discontinued Operations
-3.00 -20 47 0.00 -2.00 11 -11 -66 -10 -12 -2.00
Net Income / (Loss) Attributable to Noncontrolling Interest
3.00 2.00 4.00 3.00 3.00 2.00 4.00 2.00 2.00 3.00 3.00
Basic Earnings per Share
($0.45) ($0.35) $0.60 $1.51 ($0.76) ($0.04) $0.95 $1.92 ($0.47) ($0.80) $1.07
Weighted Average Basic Shares Outstanding
704.73M 701.78M 696.98M 692.25M 687.29M 685.56M 682.17M 679.10M 675.73M 672.52M 668.82M
Diluted Earnings per Share
($0.45) ($0.35) $0.60 $1.51 ($0.76) ($0.05) $0.95 $1.92 ($0.47) ($0.80) $1.07
Weighted Average Diluted Shares Outstanding
704.73M 701.78M 696.98M 692.25M 687.29M 685.56M 682.17M 679.10M 675.73M 672.52M 668.82M
Weighted Average Basic & Diluted Shares Outstanding
704.73M 701.78M 696.98M 692.25M 687.29M 685.56M 682.17M 679.10M 675.73M 672.52M 668.82M
Cash Dividends to Common per Share
$0.16 - - - - - $0.17 - - - $0.18

Annual Cash Flow Statements for Corteva

This table details how cash moves in and out of Corteva's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
3,613 -2,851 1,700 -198 -2,436 -920 528 2,606
Net Cash From Operating Activities
483 1,070 2,064 2,727 1,711 3,497 4,332 6,812
Net Cash From Continuing Operating Activities
374 -149 2,064 2,769 1,791 3,577 4,634 6,914
Net Income / (Loss) Continuing Operations
-5,027 -941 701 1,822 2,398 1,867 1,756 2,408
Consolidated Net Income / (Loss)
5,027 -941 701 1,769 2,282 1,479 1,868 2,210
Net Income / (Loss) Discontinued Operations
- - - -53 -116 -388 112 -198
Depreciation Expense
2,790 1,599 1,177 1,243 2,446 2,422 2,454 2,406
Non-Cash Adjustments To Reconcile Net Income
5,208 -161 19 -1,117 652 1,762 1,326 1,100
Changes in Operating Assets and Liabilities, net
-4,225 -918 167 821 -3,705 -2,474 -902 1,000
Net Cash From Discontinued Operating Activities
- - - -42 -80 -80 -302 -102
Net Cash From Investing Activities
-505 -904 -674 -362 -1,264 -3,994 -817 -1,086
Net Cash From Continuing Investing Activities
-505 -904 -674 -362 -1,264 -3,994 -817 -1,086
Purchase of Property, Plant & Equipment
-1,501 -1,163 -475 -573 -1,210 -1,190 -1,194 -1,182
Acquisitions
-8.00 -20 -1.00 -4.00 -96 -2,976 -14 -40
Purchase of Investments
-1,257 -138 -995 -204 -688 -296 -162 0.00
Divestitures
78 270 83 75 146 114 10 108
Sale and/or Maturity of Investments
2,186 160 721 345 590 378 260 104
Other Investing Activities, net
-3.00 -13 -7.00 -1.00 -6.00 -24 283 -76
Net Cash From Financing Activities
-2,624 -2,929 303 -1,266 -2,327 -137 -2,801 -3,288
Net Cash From Continuing Financing Activities
3,744 2,357 1,199 -2,563 -2,327 -137 -2,801 -3,417
Repayment of Debt
-6,422 -6,758 -1,469 -1,800 -3,823 -5,850 -5,825 -3,825
Repurchase of Common Equity
0.00 -25 -275 -950 -1,000 -756 -1,009 -1,071
Payment of Dividends
-2,806 511 -448 -397 -418 -439 -2,337 -2,157
Issuance of Debt
1,156 -867 2,439 484 2,738 6,846 6,250 3,460
Other Financing Activities, net
5,448 9,496 56 100 176 62 120 176
Other Net Changes in Cash
- -88 7.00 - -556 -286 -186 168
Cash Interest Paid
923 263 36 30 150 468 488 382
Cash Income Taxes Paid
961 234 229 341 934 1,070 1,414 1,500

Quarterly Cash Flow Statements for Corteva

This table details how cash moves in and out of Corteva's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-1,014 749 -2,288 254 1,230 1,332 -2,254 44 840 3,976 -5,168
Net Cash From Operating Activities
-105 7,829 -5,222 536 -114 9,494 -4,218 1,894 386 8,750 -5,782
Net Cash From Continuing Operating Activities
-94 7,919 -5,216 848 -118 9,482 -4,202 1,924 396 8,796 -5,770
Net Income / (Loss) Continuing Operations
-315 695 757 2,122 -1,024 -99 1,334 2,764 -616 -1,074 1,450
Consolidated Net Income / (Loss)
-318 481 851 2,122 -1,028 -77 1,312 2,632 -636 -1,098 1,446
Net Income / (Loss) Discontinued Operations
-3.00 -214 94 - -4.00 22 -22 -132 -20 -24 -4.00
Depreciation Expense
306 1,523 614 624 612 604 592 602 600 612 594
Non-Cash Adjustments To Reconcile Net Income
174 1,232 504 450 406 -34 206 544 304 46 498
Changes in Operating Assets and Liabilities, net
-222 2,701 -7,091 -2,348 -112 9,011 -6,334 -1,986 108 9,212 -8,312
Net Cash From Discontinued Operating Activities
-11 -50 -6.00 -312 4.00 12 -16 -30 -10 -46 -12
Net Cash From Investing Activities
-229 -4,228 -902 -70 -322 115 -68 -328 -314 -376 -154
Net Cash From Continuing Investing Activities
-263 -2,221 -902 -70 -322 115 61 -328 -314 -505 -154
Purchase of Property, Plant & Equipment
-162 -778 -296 -228 -308 -362 -188 -236 -314 -444 -162
Acquisitions
-20 -1,489 - - -14 - 0.00 - - -26 -6.00
Purchase of Investments
-76 -213 -264 -8.00 -2.00 -14 0.00 - - - 0.00
Divestitures
-26 72 10 30 -36 6.00 16 34 2.00 56 0.00
Sale and/or Maturity of Investments
21 209 14 146 100 126 124 -112 12 80 16
Other Investing Activities, net
- -22 -366 -10 -62 359 109 -14 - -171 -2.00
Net Cash From Financing Activities
224 -3,778 3,898 -130 1,612 -8,181 1,990 -1,616 734 -4,396 778
Net Cash From Continuing Financing Activities
-671 -2,845 3,898 -130 1,612 -8,181 1,861 -1,616 734 -4,396 778
Repayment of Debt
-1,869 -3,567 -416 -1,519 -1,172 -2,718 -74 -665 -1,572 -1,514 -92
Repurchase of Common Equity
-253 -171 -252 -252 -253 -252 -270 -250 -250 -301 -250
Payment of Dividends
-114 -112 -112 -111 -117 -1,997 -629 -491 -494 -543 -492
Issuance of Debt
1,563 971 4,662 1,712 3,150 -3,274 2,764 -280 3,040 -2,064 1,578
Other Financing Activities, net
2.00 34 16 40 4.00 60 70 70 10 26 34
Other Net Changes in Cash
- - -62 -82 54 -96 42 94 34 -2.00 -10

Annual Balance Sheets for Corteva

This table presents Corteva's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
217,366 42,397 42,649 42,344 42,618 42,996 40,825 42,845
Total Current Assets
45,944 13,519 14,768 15,546 16,795 16,260 15,097 17,335
Cash & Equivalents
4,540 1,764 3,526 4,459 3,191 2,644 3,106 4,521
Short-Term Investments
10 5.00 269 86 124 98 63 9.00
Accounts Receivable
10,520 5,528 4,926 4,811 5,701 5,488 5,676 6,371
Inventories, net
10,620 5,032 4,882 5,180 6,811 6,899 5,432 5,667
Other Current Assets
2,076 1,190 1,165 1,010 968 1,131 820 767
Plant, Property, & Equipment, net
9,088 4,546 4,396 4,329 4,254 4,287 4,099 4,220
Plant, Property & Equipment, gross
14,680 7,872 8,253 8,364 8,551 8,956 9,074 9,551
Accumulated Depreciation
5,592 3,326 3,857 4,035 4,297 4,669 4,975 5,331
Total Noncurrent Assets
162,334 24,332 23,485 22,469 21,569 22,449 21,629 21,290
Long-Term Investments
276 66 66 76 102 115 134 160
Goodwill
20,386 10,229 10,269 10,107 9,962 10,605 10,408 10,465
Intangible Assets
24,110 11,424 10,747 10,044 9,339 9,626 8,876 8,301
Noncurrent Deferred & Refundable Income Taxes
608 287 464 438 479 584 401 320
Other Noncurrent Operating Assets
3,864 2,326 1,939 1,804 1,687 1,519 1,810 2,044
Total Liabilities & Shareholders' Equity
217,366 42,397 42,649 42,344 42,618 42,996 40,825 42,845
Total Liabilities
67,060 17,842 17,586 16,721 17,077 17,717 16,795 18,459
Total Current Liabilities
26,620 8,238 8,548 9,558 10,744 10,409 10,386 12,125
Short-Term Debt
4,308 7.00 3.00 17 24 198 750 894
Accounts Payable
7,596 3,702 3,615 4,126 4,895 4,280 4,039 4,398
Accrued Expenses
8,010 4,434 2,145 2,068 2,254 2,351 2,103 3,099
Current Deferred Revenue
- - 2,662 3,201 3,388 3,406 3,287 3,579
Current Deferred & Payable Income Tax Liabilities
372 95 123 146 183 174 207 155
Total Noncurrent Liabilities
40,440 9,604 9,038 7,163 6,333 7,308 6,409 6,334
Long-Term Debt
11,568 115 1,102 1,100 1,283 2,291 1,953 1,686
Noncurrent Deferred & Payable Income Tax Liabilities
2,960 920 893 1,220 1,119 899 478 251
Noncurrent Employee Benefit Liabilities
11,354 6,377 5,176 3,124 2,255 2,467 2,271 2,434
Other Noncurrent Operating Liabilities
3,590 2,192 1,867 1,719 1,676 1,651 1,707 1,963
Total Equity & Noncontrolling Interests
150,306 24,555 25,063 25,623 25,541 25,279 24,030 24,386
Total Preferred & Common Equity
149,559 24,309 24,824 25,384 25,302 25,037 23,789 24,144
Preferred Stock
0.00 - - 0.00 0.00 0.00 0.00 0.00
Total Common Equity
149,559 24,309 24,824 25,384 25,302 25,037 23,789 24,144
Common Stock
0.00 28,004 27,714 27,758 27,858 27,755 27,203 27,008
Retained Earnings
0.00 -425 - 524 250 -41 55 -67
Accumulated Other Comprehensive Income / (Loss)
-6,720 -3,270 -2,890 -2,898 -2,806 -2,677 -3,469 -2,797
Noncontrolling Interest
747 246 239 239 239 242 241 242

Quarterly Balance Sheets for Corteva

This table presents Corteva's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
44,189 43,110 42,996 43,625 41,464 41,908 40,825 42,123 41,759 42,198 42,717
Total Current Assets
17,207 16,333 16,260 17,163 15,359 15,649 15,097 16,587 16,004 16,438 17,385
Cash & Equivalents
2,563 2,254 2,644 1,505 1,839 2,421 3,106 2,008 2,065 2,509 1,964
Short-Term Investments
53 108 98 153 120 72 63 1.00 76 77 2.00
Accounts Receivable
7,955 6,581 5,488 7,906 7,615 6,651 5,676 8,294 8,674 7,784 9,088
Inventories, net
5,628 6,320 6,899 6,183 4,893 5,674 5,432 5,132 4,316 5,310 5,202
Other Current Assets
1,008 1,070 1,131 1,416 892 831 820 1,152 873 758 1,129
Plant, Property, & Equipment, net
4,306 4,320 4,287 4,206 4,155 4,210 4,099 4,105 4,153 4,202 4,183
Plant, Property & Equipment, gross
8,797 8,892 8,956 9,013 9,088 9,235 9,074 9,244 9,455 9,633 9,617
Accumulated Depreciation
4,491 4,572 4,669 4,807 4,933 5,025 4,975 5,139 5,302 5,431 5,434
Total Noncurrent Assets
22,676 22,457 22,449 22,256 21,950 22,049 21,629 21,431 21,602 21,558 21,149
Long-Term Investments
83 106 115 123 113 128 134 136 134 141 165
Goodwill
10,539 10,441 10,605 10,553 10,490 10,629 10,408 10,332 10,518 10,512 10,409
Intangible Assets
9,985 9,795 9,626 9,446 9,238 9,084 8,876 8,718 8,583 8,428 8,147
Noncurrent Deferred & Refundable Income Taxes
524 554 584 551 538 564 401 413 449 434 395
Other Noncurrent Operating Assets
1,545 1,561 1,519 1,583 1,571 1,644 1,810 1,832 1,918 2,043 2,033
Total Liabilities & Shareholders' Equity
44,189 43,110 42,996 43,625 41,464 41,908 40,825 42,123 41,759 42,198 42,717
Total Liabilities
17,728 17,758 17,717 18,617 16,043 16,929 16,795 17,596 15,608 16,737 18,112
Total Current Liabilities
10,346 10,348 10,409 11,332 8,953 10,424 10,386 11,481 9,516 10,420 11,854
Short-Term Debt
3,023 3,724 198 2,148 2,253 3,741 750 2,291 1,942 2,685 1,674
Accounts Payable
3,379 3,678 4,280 3,606 3,300 3,753 4,039 3,905 3,828 4,337 4,187
Accrued Expenses
2,892 2,273 2,351 2,573 2,499 2,188 2,103 2,332 2,903 2,661 2,991
Current Deferred Revenue
656 552 3,406 2,694 413 429 3,287 2,631 358 483 2,773
Current Deferred & Payable Income Tax Liabilities
396 236 174 311 488 313 207 322 485 254 229
Total Noncurrent Liabilities
7,382 7,295 7,308 7,285 7,090 6,505 6,409 6,115 6,092 6,317 6,258
Long-Term Debt
2,290 2,290 2,291 2,492 2,471 1,975 1,953 1,792 1,687 1,688 1,682
Noncurrent Deferred & Payable Income Tax Liabilities
1,134 1,070 899 753 607 496 478 369 258 373 290
Noncurrent Employee Benefit Liabilities
2,236 2,228 2,467 2,453 2,452 2,473 2,271 2,239 2,229 2,215 2,388
Other Noncurrent Operating Liabilities
1,722 1,707 1,651 1,587 1,560 1,561 1,707 1,715 1,918 2,041 1,898
Total Equity & Noncontrolling Interests
26,461 25,467 25,279 25,008 25,421 24,979 24,030 24,527 26,151 25,461 24,605
Total Preferred & Common Equity
26,220 25,226 25,037 24,767 25,179 24,737 23,789 24,285 25,909 25,219 24,362
Preferred Stock
0.00 239 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
26,220 25,226 25,037 24,767 25,179 24,737 23,789 24,285 25,909 25,219 24,362
Common Stock
27,884 27,902 27,755 27,475 27,511 27,525 27,203 26,969 27,021 27,046 26,866
Retained Earnings
1,013 325 -41 302 992 98 55 587 1,532 834 436
Accumulated Other Comprehensive Income / (Loss)
-2,677 -3,001 -2,677 -3,010 -3,324 -2,886 -3,469 -3,271 -2,644 -2,661 -2,940
Noncontrolling Interest
241 241 242 241 242 242 241 242 242 242 243

Annual Metrics And Ratios for Corteva

This table displays calculated financial ratios and metrics derived from Corteva's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% -3.09% 2.68% 10.11% 11.50% -1.31% -1.85% 2.92%
EBITDA Growth
0.00% 186.50% 11.33% 90.77% 9.17% -5.14% 5.71% 7.87%
EBIT Growth
0.00% 97.39% 531.14% 230.00% -36.66% -11.89% 13.73% 23.87%
NOPAT Growth
0.00% 94.24% 312.77% 40.32% 67.15% 14.44% -19.87% 42.10%
Net Income Growth
0.00% 81.28% 174.50% 152.35% -34.54% -35.49% 23.03% 20.24%
EPS Growth
0.00% 81.07% 171.09% 160.44% -33.33% -34.81% 26.21% 23.08%
Operating Cash Flow Growth
0.00% 121.53% 92.90% 32.12% -37.26% 205.38% -17.09% 57.25%
Free Cash Flow Firm Growth
0.00% 0.00% -95.45% -10.65% -97.72% 109.92% 5,618.87% 6.96%
Invested Capital Growth
0.00% -51.80% -2.34% -0.84% 5.93% 6.32% -5.95% -4.93%
Revenue Q/Q Growth
0.00% 113.31% 34.16% 1.77% 2.02% -0.68% 1.63% -0.39%
EBITDA Q/Q Growth
0.00% -57.15% -42.09% 9.73% -3.16% 119.95% 21.50% -12.74%
EBIT Q/Q Growth
0.00% -104.31% -11.00% 15.17% -21.82% -6.62% 37.22% -25.28%
NOPAT Q/Q Growth
0.00% -107.25% -3.18% -4.16% 27.01% -18.86% 2.54% -0.61%
Net Income Q/Q Growth
0.00% -128.66% 51.08% 7.15% -15.60% -20.95% 29.99% -31.58%
EPS Q/Q Growth
0.00% 0.00% 10.98% 7.24% -15.51% -21.37% 30.00% -31.91%
Operating Cash Flow Q/Q Growth
0.00% 11.46% -3.37% 9.87% 327.53% 103.62% 649.05% 5.37%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% -60.48% 5.16% -12.33% 103.18% 34.07% 6.49%
Invested Capital Q/Q Growth
0.00% -14.81% -9.35% -9.73% -8.21% -13.80% -16.54% -17.82%
Profitability Metrics
- - - - - - - -
Gross Margin
30.37% 38.07% 40.16% 41.11% 40.21% 42.41% 43.64% 47.29%
EBITDA Margin
-13.79% 12.31% 13.34% 23.12% 22.64% 21.76% 23.43% 24.56%
Operating Margin
-46.45% -2.76% 3.57% 6.57% 8.97% 10.30% 10.69% 14.01%
EBIT Margin
-44.71% -1.21% 5.06% 15.18% 8.62% 7.70% 8.92% 10.74%
Profit (Net Income) Margin
-35.19% -6.80% 4.93% 11.30% 6.63% 4.34% 5.44% 6.35%
Tax Burden Percent
73.86% 297.78% 103.85% 75.40% 81.21% 68.34% 72.08% 65.46%
Interest Burden Percent
106.54% 189.22% 93.75% 98.74% 94.75% 82.43% 84.55% 90.36%
Effective Tax Rate
0.00% 0.00% -12.00% 22.34% 14.73% 13.91% 32.31% 28.67%
Return on Invested Capital (ROIC)
-9.80% -0.76% 2.52% 3.59% 5.86% 6.32% 5.06% 7.61%
ROIC Less NNEP Spread (ROIC-NNEP)
-9.43% 0.53% -3.39% -27.42% 12.15% 69.30% 68.03% 54.40%
Return on Net Nonoperating Assets (RNNOA)
6.46% -0.31% 0.31% 3.39% -1.33% -3.38% -1.34% -3.04%
Return on Equity (ROE)
-3.34% -1.08% 2.83% 6.98% 4.53% 2.94% 3.73% 4.56%
Cash Return on Invested Capital (CROIC)
0.00% 69.14% 4.89% 4.44% 0.10% 0.20% 11.19% 12.66%
Operating Return on Assets (OROA)
-2.94% -0.13% 1.69% 5.59% 3.54% 3.10% 3.60% 4.47%
Return on Assets (ROA)
-2.31% -0.72% 1.65% 4.16% 2.73% 1.75% 2.19% 2.64%
Return on Common Equity (ROCE)
-3.33% -1.07% 2.80% 6.91% 4.48% 2.91% 3.69% 4.52%
Return on Equity Simple (ROE_SIMPLE)
-3.36% -3.87% 2.82% 6.97% 4.58% 2.98% 3.86% 0.00%
Net Operating Profit after Tax (NOPAT)
-4,646 -267 569 798 1,335 1,527 1,224 1,739
NOPAT Margin
-32.52% -1.93% 4.00% 5.10% 7.65% 8.87% 7.24% 9.99%
Net Nonoperating Expense Percent (NNEP)
-0.37% -1.29% 5.91% 31.01% -6.29% -62.98% -62.97% -46.79%
Return On Investment Capital (ROIC_SIMPLE)
- - - - 4.97% 5.50% 4.58% 6.45%
Cost of Revenue to Revenue
69.63% 61.93% 59.84% 58.89% 59.79% 57.59% 56.36% 52.71%
SG&A Expenses to Revenue
21.29% 22.14% 21.40% 20.50% 18.18% 18.44% 18.90% 20.07%
R&D to Revenue
9.48% 8.28% 8.03% 7.58% 6.97% 7.76% 8.29% 8.47%
Operating Expenses to Revenue
76.83% 40.83% 36.59% 34.54% 31.25% 32.11% 32.95% 33.28%
Earnings before Interest and Taxes (EBIT)
-6,388 -167 720 2,376 1,505 1,326 1,508 1,868
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-1,970 1,704 1,897 3,619 3,951 3,748 3,962 4,274
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
0.00 0.86 1.12 1.33 1.62 1.33 1.65 1.88
Price to Tangible Book Value (P/TBV)
0.00 7.89 7.31 6.43 6.84 6.95 8.69 8.42
Price to Revenue (P/Rev)
0.00 1.51 1.96 2.15 2.35 1.94 2.32 2.60
Price to Earnings (P/E)
0.00 0.00 40.87 19.13 35.77 45.42 43.16 41.40
Dividend Yield
0.00% 0.93% 1.74% 1.17% 1.27% 1.31% 1.16% 1.04%
Earnings Yield
0.00% 0.00% 2.45% 5.23% 2.80% 2.20% 2.32% 2.42%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.85 1.13 1.37 1.67 1.34 1.66 1.95
Enterprise Value to Revenue (EV/Rev)
0.00 1.41 1.78 1.94 2.24 1.93 2.29 2.50
Enterprise Value to EBITDA (EV/EBITDA)
0.00 11.43 13.34 8.39 9.91 8.87 9.79 10.16
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 35.16 12.79 26.02 25.08 25.72 23.25
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 44.49 38.05 29.34 21.78 31.70 24.97
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 18.20 12.26 11.14 22.89 6.37 8.95 6.38
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.80 22.93 30.80 1,738.05 703.19 14.34 15.01
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.11 0.01 0.04 0.04 0.05 0.10 0.11 0.11
Long-Term Debt to Equity
0.08 0.00 0.04 0.04 0.05 0.09 0.08 0.07
Financial Leverage
-0.68 -0.60 -0.09 -0.12 -0.11 -0.05 -0.02 -0.06
Leverage Ratio
1.45 1.49 1.71 1.68 1.66 1.68 1.70 1.73
Compound Leverage Factor
1.54 2.81 1.61 1.66 1.57 1.39 1.44 1.56
Debt to Total Capital
9.55% 0.49% 4.22% 4.18% 4.87% 8.96% 10.11% 9.57%
Short-Term Debt to Total Capital
2.59% 0.03% 0.01% 0.06% 0.09% 0.71% 2.81% 3.32%
Long-Term Debt to Total Capital
6.96% 0.47% 4.21% 4.11% 4.78% 8.25% 7.31% 6.25%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.45% 1.00% 0.91% 0.89% 0.89% 0.87% 0.90% 0.90%
Common Equity to Total Capital
90.00% 98.51% 94.86% 94.93% 94.24% 90.16% 88.99% 89.54%
Debt to EBITDA
-8.06 0.07 0.58 0.31 0.33 0.66 0.68 0.60
Net Debt to EBITDA
-5.61 -1.01 -1.45 -0.97 -0.53 -0.10 -0.15 -0.49
Long-Term Debt to EBITDA
-5.87 0.07 0.58 0.30 0.32 0.61 0.49 0.39
Debt to NOPAT
-3.42 -0.46 1.94 1.40 0.98 1.63 2.21 1.48
Net Debt to NOPAT
-2.38 6.41 -4.84 -4.39 -1.58 -0.24 -0.49 -1.21
Long-Term Debt to NOPAT
-2.49 -0.43 1.94 1.38 0.96 1.50 1.60 0.97
Altman Z-Score
0.00 1.15 1.51 1.95 2.15 1.79 2.08 2.17
Noncontrolling Interest Sharing Ratio
0.50% 0.57% 0.98% 0.94% 0.93% 0.95% 0.98% 1.00%
Liquidity Ratios
- - - - - - - -
Current Ratio
1.73 1.64 1.73 1.63 1.56 1.56 1.45 1.43
Quick Ratio
0.57 0.89 1.02 0.98 0.84 0.79 0.85 0.90
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 24,281 1,104 986 23 47 2,705 2,893
Operating Cash Flow to CapEx
32.18% 92.00% 434.53% 475.92% 141.41% 439.08% 362.81% 576.31%
Free Cash Flow to Firm to Interest Expense
0.00 162.96 24.53 32.88 0.29 0.20 11.61 16.07
Operating Cash Flow to Interest Expense
1.16 7.18 45.87 90.90 21.66 22.42 18.59 37.84
Operating Cash Flow Less CapEx to Interest Expense
-2.44 -0.62 35.31 71.80 6.34 17.32 13.47 31.28
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.07 0.11 0.33 0.37 0.41 0.40 0.40 0.42
Accounts Receivable Turnover
1.36 1.73 2.72 3.22 3.32 3.08 3.03 2.89
Inventory Turnover
0.94 1.10 1.72 1.83 1.74 1.45 1.55 1.65
Fixed Asset Turnover
1.57 2.03 3.18 3.59 4.07 4.03 4.03 4.18
Accounts Payable Turnover
1.31 1.52 2.33 2.38 2.31 2.16 2.29 2.17
Days Sales Outstanding (DSO)
268.76 211.52 134.20 113.51 109.91 118.54 120.50 126.35
Days Inventory Outstanding (DIO)
389.66 333.12 212.68 199.17 209.69 252.23 236.16 220.84
Days Payable Outstanding (DPO)
278.70 240.45 156.97 153.22 157.76 168.79 159.33 167.88
Cash Conversion Cycle (CCC)
379.71 304.19 189.91 159.45 161.85 201.97 197.34 179.32
Capital & Investment Metrics
- - - - - - - -
Invested Capital
47,390 22,842 22,307 22,119 23,431 24,911 23,430 22,276
Invested Capital Turnover
0.30 0.39 0.63 0.70 0.77 0.71 0.70 0.76
Increase / (Decrease) in Invested Capital
0.00 -24,548 -535 -188 1,312 1,480 -1,481 -1,154
Enterprise Value (EV)
0.00 19,477 25,314 30,377 39,159 33,258 38,789 43,426
Market Capitalization
0.00 20,944 27,831 33,642 41,030 33,384 39,148 45,294
Book Value per Share
$0.00 $32.48 $33.32 $34.82 $35.41 $35.53 $34.61 $35.73
Tangible Book Value per Share
$0.00 $3.55 $5.11 $7.18 $8.40 $6.82 $6.55 $7.96
Total Capital
166,182 24,677 26,168 26,740 26,848 27,768 26,733 26,966
Total Debt
15,876 122 1,105 1,117 1,307 2,489 2,703 2,580
Total Long-Term Debt
11,568 115 1,102 1,100 1,283 2,291 1,953 1,686
Net Debt
11,050 -1,713 -2,756 -3,504 -2,110 -368 -600 -2,110
Capital Expenditures (CapEx)
1,501 1,163 475 573 1,210 1,190 1,194 1,182
Debt-free, Cash-free Net Working Capital (DFCFNWC)
19,082 3,519 2,428 1,460 2,760 3,307 2,292 1,574
Debt-free Net Working Capital (DFNWC)
23,632 5,288 6,223 6,005 6,075 6,049 5,461 6,104
Net Working Capital (NWC)
19,324 5,281 6,220 5,988 6,051 5,851 4,711 5,210
Net Nonoperating Expense (NNE)
381 674 -132 -971 177 780 305 634
Net Nonoperating Obligations (NNO)
-102,916 -1,713 -2,756 -3,504 -2,110 -368 -600 -2,110
Total Depreciation and Amortization (D&A)
4,418 1,871 1,177 1,243 2,446 2,422 2,454 2,406
Debt-free, Cash-free Net Working Capital to Revenue
133.56% 25.42% 17.08% 9.33% 15.81% 19.20% 13.56% 9.05%
Debt-free Net Working Capital to Revenue
165.41% 38.19% 43.77% 38.36% 34.80% 35.12% 32.30% 35.08%
Net Working Capital to Revenue
135.26% 38.14% 43.75% 38.25% 34.67% 33.97% 27.86% 29.94%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
($6.76) ($1.28) $0.91 $2.39 $1.59 $1.04 $1.31 $1.60
Adjusted Weighted Average Basic Shares Outstanding
0.00 749.40M 744.06M 727.02M 712.82M 701.78M 685.56M 672.52M
Adjusted Diluted Earnings per Share
($6.76) ($1.28) $0.91 $2.37 $1.58 $1.03 $1.30 $1.60
Adjusted Weighted Average Diluted Shares Outstanding
0.00 749.40M 744.06M 727.02M 712.82M 701.78M 685.56M 672.52M
Adjusted Basic & Diluted Earnings per Share
($6.76) ($1.28) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 749.40M 744.06M 727.02M 712.82M 701.78M 685.56M 672.52M
Normalized Net Operating Profit after Tax (NOPAT)
-1,008 -112 590 1,023 1,644 1,817 1,419 1,843
Normalized NOPAT Margin
-7.06% -0.81% 4.15% 6.53% 9.42% 10.55% 8.39% 10.59%
Pre Tax Income Margin
-47.64% -2.28% 4.75% 14.99% 8.17% 6.35% 7.54% 9.70%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
-15.28 -1.12 16.00 79.20 19.05 5.69 6.47 10.38
NOPAT to Interest Expense
-11.11 -1.79 12.64 26.61 16.89 6.55 5.25 9.66
EBIT Less CapEx to Interest Expense
-18.87 -8.93 5.44 60.10 3.73 0.58 1.35 3.81
NOPAT Less CapEx to Interest Expense
-14.71 -9.60 2.09 7.51 1.58 1.45 0.13 3.09
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
-55.82% 54.30% 63.91% 22.44% 36.10% 58.77% 254.30% 195.20%
Augmented Payout Ratio
-55.82% 51.65% 103.14% 76.14% 122.45% 159.97% 364.09% 292.13%

Quarterly Metrics And Ratios for Corteva

This table displays calculated financial ratios and metrics derived from Corteva's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 672,163,200.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 672,163,200.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.07
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-6.73% -3.09% -8.03% 1.11% -10.19% 7.31% -1.67% 5.63% 12.55% -1.71% 11.05%
EBITDA Growth
60.00% 186.17% 17.58% 51.34% 156.25% -40.41% 24.19% 21.20% 513.33% -82.98% 5.38%
EBIT Growth
-2.12% -56.29% -35.19% 20.41% -46.89% 156.71% 56.79% 32.19% 42.86% -427.03% 9.02%
NOPAT Growth
40.90% -509.18% -29.35% 13.45% -94.09% 37.30% 41.15% 12.17% 34.57% 272.86% 24.74%
Net Income Growth
3.05% -373.58% -29.38% 47.28% -63.84% 84.46% 55.08% 24.62% 38.96% -1,307.69% 10.21%
EPS Growth
2.17% -400.00% -27.71% 51.00% -68.89% 85.71% 58.33% 27.15% 38.16% -1,500.00% 12.63%
Operating Cash Flow Growth
96.08% 30.29% -68.65% -33.99% -8.57% 21.27% 19.23% 111.15% 51.97% 4.13% -37.08%
Free Cash Flow Firm Growth
-170.80% -19.96% 162.53% 181.40% 114.20% 188.15% 25.17% -13.11% 50.66% -9.02% -28.64%
Invested Capital Growth
13.20% 6.32% -4.07% -3.45% -2.85% -5.95% -5.03% -2.02% -3.44% -4.93% -2.40%
Revenue Q/Q Growth
-57.15% 43.13% 21.18% 36.06% -61.94% 71.02% 11.04% 46.16% -59.45% 49.35% 25.45%
EBITDA Q/Q Growth
-105.97% 1,677.50% 234.08% 78.36% -97.78% 1,571.11% 87.77% 74.08% -88.77% -53.62% 1,062.50%
EBIT Q/Q Growth
-133.10% 32.38% 300.38% 168.45% -140.38% 126.10% 454.05% 126.34% -117.46% -49.38% 284.71%
NOPAT Q/Q Growth
-115.72% 29.54% 376.75% 146.75% -126.89% 77.24% 1,034.39% 96.09% -115.69% 160.13% 574.26%
Net Income Q/Q Growth
-144.35% 21.07% 268.53% 149.65% -149.34% 92.51% 1,782.05% 100.61% -124.16% -72.64% 231.69%
EPS Q/Q Growth
-145.00% 22.22% 271.43% 151.67% -150.33% 93.42% 2,000.00% 102.11% -124.48% -70.21% 233.75%
Operating Cash Flow Q/Q Growth
-112.93% 7,556.19% -179.91% 109.60% -121.27% 8,428.07% -144.43% 144.90% -79.62% 2,166.84% -166.08%
Free Cash Flow Firm Q/Q Growth
-30.88% 54.84% 200.72% 31.91% -77.17% 180.42% 48.25% -8.43% -60.42% 69.34% 16.29%
Invested Capital Q/Q Growth
-0.61% -13.80% 11.87% 0.74% 0.00% -16.54% 12.95% 3.93% -1.45% -17.82% 15.95%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
36.45% 36.17% 43.23% 52.26% 32.72% 37.25% 46.98% 54.58% 37.20% 42.35% 51.64%
EBITDA Margin
-3.09% 34.04% 25.31% 33.18% 1.93% 18.90% 31.97% 38.07% 10.54% 3.27% 30.34%
Operating Margin
-9.15% -4.51% 13.85% 24.82% -19.78% 3.24% 18.23% 27.15% -11.50% 4.63% 20.61%
EBIT Margin
-14.90% -7.04% 11.64% 22.97% -24.38% 3.72% 18.56% 28.75% -12.38% -12.38% 18.23%
Profit (Net Income) Margin
-12.28% -6.77% 9.42% 17.28% -22.40% -0.98% 14.85% 20.38% -12.15% -14.04% 14.74%
Tax Burden Percent
71.62% 77.71% 87.76% 78.92% 82.31% -44.32% 83.67% 72.95% 85.95% 103.58% 84.27%
Interest Burden Percent
115.03% 123.75% 92.16% 95.30% 111.64% 59.46% 95.61% 97.20% 114.20% 109.50% 95.97%
Effective Tax Rate
0.00% 0.00% 21.99% 21.08% 0.00% 156.82% 14.92% 23.39% 0.00% 0.00% 15.50%
Return on Invested Capital (ROIC)
-4.08% -2.25% 6.39% 11.59% -8.09% -1.29% 9.61% 12.86% -5.10% 2.47% 11.92%
ROIC Less NNEP Spread (ROIC-NNEP)
-11.93% 8.58% 4.34% 6.22% -14.18% -8.37% 8.40% 11.51% -9.62% 52.33% 3.61%
Return on Net Nonoperating Assets (RNNOA)
-0.91% -0.42% 0.52% 0.63% -1.83% 0.16% 0.81% 0.89% -0.90% -2.93% 0.23%
Return on Equity (ROE)
-5.00% -2.67% 6.91% 12.22% -9.92% -1.12% 10.42% 13.75% -6.00% -0.46% 12.15%
Cash Return on Invested Capital (CROIC)
-5.47% 0.20% 8.89% 8.62% 7.08% 11.19% 10.52% 7.85% 9.85% 12.66% 9.67%
Operating Return on Assets (OROA)
-6.17% -2.83% 4.40% 9.07% -9.54% 1.50% 7.29% 11.87% -5.14% -5.15% 7.69%
Return on Assets (ROA)
-5.08% -2.72% 3.56% 6.82% -8.77% -0.40% 5.83% 8.41% -5.05% -5.84% 6.22%
Return on Common Equity (ROCE)
-4.95% -2.64% 6.84% 12.10% -9.83% -1.11% 10.32% 13.62% -5.94% -0.46% 12.03%
Return on Equity Simple (ROE_SIMPLE)
3.75% 0.00% 2.31% 3.61% 2.86% 0.00% 4.74% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-166 -117 485 1,197 -322 -73 685 1,343 -211 127 854
NOPAT Margin
-6.41% -3.15% 10.80% 19.59% -13.84% -1.84% 15.51% 20.80% -8.05% 3.24% 17.42%
Net Nonoperating Expense Percent (NNEP)
7.85% -10.82% 2.05% 5.37% 6.10% 7.09% 1.20% 1.34% 4.53% -49.87% 8.30%
Return On Investment Capital (ROIC_SIMPLE)
- -0.42% - - - -0.27% 2.39% 4.51% -0.71% 0.47% 3.06%
Cost of Revenue to Revenue
63.55% 63.83% 56.77% 47.74% 67.28% 62.75% 53.02% 45.42% 62.80% 57.65% 48.36%
SG&A Expenses to Revenue
25.87% 19.83% 16.38% 17.24% 28.85% 18.48% 17.00% 17.91% 27.69% 21.99% 17.88%
R&D to Revenue
12.93% 9.63% 7.39% 5.84% 14.96% 9.18% 7.58% 5.81% 13.41% 10.56% 6.95%
Operating Expenses to Revenue
45.60% 40.68% 29.39% 27.44% 52.49% 34.01% 28.75% 27.43% 48.70% 37.72% 31.03%
Earnings before Interest and Taxes (EBIT)
-386 -261 523 1,404 -567 148 820 1,856 -324 -484 894
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-80 1,262 1,137 2,028 45 752 1,412 2,458 276 128 1,488
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.42 1.33 1.64 1.49 1.65 1.65 1.78 1.96 1.82 1.88 2.31
Price to Tangible Book Value (P/TBV)
7.19 6.95 8.52 6.90 8.10 8.69 8.24 7.47 7.31 8.42 9.69
Price to Revenue (P/Rev)
2.07 1.94 2.41 2.22 2.45 2.32 2.56 2.96 2.63 2.60 3.15
Price to Earnings (P/E)
38.44 45.42 72.70 41.87 58.56 43.16 37.84 36.29 28.62 41.40 48.42
Dividend Yield
1.50% 1.31% 1.09% 1.19% 1.11% 1.16% 1.06% 0.91% 1.02% 1.04% 0.85%
Earnings Yield
2.60% 2.20% 1.38% 2.39% 1.71% 2.32% 2.64% 2.76% 3.49% 2.42% 2.07%
Enterprise Value to Invested Capital (EV/IC)
1.38 1.34 1.57 1.44 1.58 1.66 1.71 1.91 1.76 1.95 2.24
Enterprise Value to Revenue (EV/Rev)
2.30 1.93 2.60 2.40 2.66 2.29 2.69 3.05 2.74 2.50 3.23
Enterprise Value to EBITDA (EV/EBITDA)
23.41 8.87 25.11 12.91 13.58 9.79 10.70 11.24 9.76 10.16 13.27
Enterprise Value to EBIT (EV/EBIT)
28.09 25.08 41.98 31.63 40.29 25.72 25.11 23.23 19.13 23.25 29.73
Enterprise Value to NOPAT (EV/NOPAT)
21.19 21.78 32.43 27.74 37.10 31.70 31.11 32.50 27.33 24.97 30.49
Enterprise Value to Operating Cash Flow (EV/OCF)
15.55 6.37 0.00 0.00 0.00 8.95 8.49 8.28 7.40 6.38 11.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 703.19 17.28 16.45 21.94 14.34 15.85 24.04 17.60 15.01 22.83
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.24 0.10 0.19 0.19 0.23 0.11 0.17 0.14 0.17 0.11 0.14
Long-Term Debt to Equity
0.09 0.09 0.10 0.10 0.08 0.08 0.07 0.06 0.07 0.07 0.07
Financial Leverage
0.08 -0.05 0.12 0.10 0.13 -0.02 0.10 0.08 0.09 -0.06 0.06
Leverage Ratio
1.66 1.68 1.75 1.65 1.69 1.70 1.73 1.61 1.67 1.73 1.73
Compound Leverage Factor
1.91 2.08 1.62 1.57 1.88 1.01 1.66 1.57 1.90 1.89 1.66
Debt to Total Capital
19.10% 8.96% 15.65% 15.67% 18.62% 10.11% 14.27% 12.19% 14.66% 9.57% 12.00%
Short-Term Debt to Total Capital
11.83% 0.71% 7.25% 7.47% 12.19% 2.81% 8.01% 6.52% 9.00% 3.32% 5.99%
Long-Term Debt to Total Capital
7.27% 8.25% 8.41% 8.20% 6.43% 7.31% 6.26% 5.66% 5.66% 6.25% 6.02%
Preferred Equity to Total Capital
0.76% 0.00% 0.00% 0.00% 0.78% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.77% 0.87% 0.81% 0.80% 0.79% 0.90% 0.85% 0.81% 0.81% 0.90% 0.87%
Common Equity to Total Capital
80.13% 90.16% 83.54% 83.53% 80.59% 88.99% 84.88% 87.00% 84.53% 89.54% 87.13%
Debt to EBITDA
3.53 0.66 2.66 1.51 1.75 0.68 0.96 0.78 0.89 0.60 0.77
Net Debt to EBITDA
2.08 -0.10 1.64 0.85 0.95 -0.15 0.46 0.29 0.34 -0.49 0.28
Long-Term Debt to EBITDA
1.34 0.61 1.43 0.79 0.61 0.49 0.42 0.36 0.34 0.39 0.39
Debt to NOPAT
3.20 1.63 3.44 3.24 4.79 2.21 2.80 2.25 2.50 1.48 1.77
Net Debt to NOPAT
1.88 -0.24 2.12 1.82 2.59 -0.49 1.33 0.84 0.94 -1.21 0.65
Long-Term Debt to NOPAT
1.22 1.50 1.85 1.69 1.65 1.60 1.23 1.05 0.96 0.97 0.89
Altman Z-Score
1.76 1.67 1.91 2.14 1.95 1.97 2.10 2.75 2.23 1.98 2.52
Noncontrolling Interest Sharing Ratio
0.95% 0.95% 0.95% 0.93% 0.96% 0.98% 0.98% 0.94% 0.96% 1.00% 0.99%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.58 1.56 1.51 1.72 1.50 1.45 1.44 1.68 1.58 1.43 1.47
Quick Ratio
0.86 0.79 0.84 1.07 0.88 0.85 0.90 1.14 1.00 0.90 0.93
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-3,536 -1,597 1,667 2,199 502 1,408 2,087 1,911 756 1,281 1,489
Operating Cash Flow to CapEx
-64.81% 1,006.30% -1,886.49% 235.09% -37.01% 2,622.65% -2,243.62% 802.54% 122.93% 1,970.72% -3,569.14%
Free Cash Flow to Firm to Interest Expense
-60.96 -25.76 40.66 33.32 7.61 23.46 57.97 36.75 16.44 27.84 41.37
Operating Cash Flow to Interest Expense
-1.81 126.27 -136.20 8.12 -1.73 158.23 -117.17 36.42 8.39 190.22 -160.61
Operating Cash Flow Less CapEx to Interest Expense
-4.60 113.73 -143.41 4.67 -6.39 152.20 -122.39 31.88 1.57 180.57 -165.11
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.41 0.40 0.38 0.39 0.39 0.40 0.39 0.41 0.42 0.42 0.42
Accounts Receivable Turnover
2.70 3.08 2.03 2.17 2.51 3.03 2.08 2.11 2.42 2.89 2.06
Inventory Turnover
1.72 1.45 1.52 1.80 1.57 1.55 1.65 2.03 1.71 1.65 1.78
Fixed Asset Turnover
4.08 4.03 3.97 4.00 3.90 4.03 4.05 4.14 4.15 4.18 4.32
Accounts Payable Turnover
2.57 2.16 2.56 2.84 2.53 2.29 2.48 2.62 2.33 2.17 2.27
Days Sales Outstanding (DSO)
135.25 118.54 179.79 168.13 145.15 120.50 175.64 173.07 150.80 126.35 177.33
Days Inventory Outstanding (DIO)
212.80 252.23 240.25 202.54 232.89 236.16 221.54 180.04 212.94 220.84 204.95
Days Payable Outstanding (DPO)
141.77 168.79 142.31 128.58 144.29 159.33 147.06 139.35 156.83 167.88 160.49
Cash Conversion Cycle (CCC)
206.29 201.97 277.73 242.09 233.75 197.34 250.12 213.75 206.91 179.32 221.79
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
28,898 24,911 27,867 28,073 28,074 23,430 26,465 27,505 27,107 22,276 25,830
Invested Capital Turnover
0.64 0.71 0.59 0.59 0.58 0.70 0.62 0.62 0.63 0.76 0.68
Increase / (Decrease) in Invested Capital
3,370 1,480 -1,182 -1,002 -824 -1,481 -1,402 -568 -967 -1,154 -635
Enterprise Value (EV)
39,893 33,258 43,742 40,489 44,273 38,789 45,322 52,438 47,816 43,426 57,735
Market Capitalization
35,867 33,384 40,642 37,595 40,697 39,148 43,142 50,842 45,928 45,294 56,267
Book Value per Share
$35.54 $35.53 $35.53 $36.13 $35.73 $34.61 $35.42 $37.98 $37.14 $35.73 $36.24
Tangible Book Value per Share
$7.03 $6.82 $6.84 $7.82 $7.26 $6.55 $7.64 $9.98 $9.25 $7.96 $8.64
Total Capital
31,481 27,768 29,648 30,145 30,695 26,733 28,610 29,780 29,834 26,966 27,961
Total Debt
6,014 2,489 4,640 4,724 5,716 2,703 4,083 3,629 4,373 2,580 3,356
Total Long-Term Debt
2,290 2,291 2,492 2,471 1,975 1,953 1,792 1,687 1,688 1,686 1,682
Net Debt
3,546 -368 2,859 2,652 3,095 -600 1,938 1,354 1,646 -2,110 1,225
Capital Expenditures (CapEx)
162 778 296 228 308 362 188 236 314 444 162
Debt-free, Cash-free Net Working Capital (DFCFNWC)
7,347 3,307 6,321 6,700 6,473 2,292 5,388 6,289 6,117 1,574 5,239
Debt-free Net Working Capital (DFNWC)
9,709 6,049 7,979 8,659 8,966 5,461 7,397 8,430 8,703 6,104 7,205
Net Working Capital (NWC)
5,985 5,851 5,831 6,406 5,225 4,711 5,106 6,488 6,018 5,210 5,531
Net Nonoperating Expense (NNE)
152 134 62 141 199 -34 29 27 107 676 131
Net Nonoperating Obligations (NNO)
3,431 -368 2,859 2,652 3,095 -600 1,938 1,354 1,646 -2,110 1,225
Total Depreciation and Amortization (D&A)
306 1,523 614 624 612 604 592 602 600 612 594
Debt-free, Cash-free Net Working Capital to Revenue
42.36% 19.20% 37.55% 39.64% 38.91% 13.56% 32.01% 36.61% 35.02% 9.05% 29.29%
Debt-free Net Working Capital to Revenue
55.98% 35.12% 47.40% 51.23% 53.89% 32.30% 43.94% 49.08% 49.82% 35.08% 40.28%
Net Working Capital to Revenue
34.51% 33.97% 34.64% 37.90% 31.41% 27.86% 30.33% 37.77% 34.45% 29.94% 30.92%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.45) ($0.35) $0.60 $1.51 ($0.76) ($0.04) $0.95 $1.92 ($0.47) ($0.80) $1.07
Adjusted Weighted Average Basic Shares Outstanding
704.73M 701.78M 696.98M 692.25M 687.29M 685.56M 682.17M 679.10M 675.73M 672.52M 668.82M
Adjusted Diluted Earnings per Share
($0.45) ($0.35) $0.60 $1.51 ($0.76) ($0.05) $0.95 $1.92 ($0.47) ($0.80) $1.07
Adjusted Weighted Average Diluted Shares Outstanding
704.73M 701.78M 696.98M 692.25M 687.29M 685.56M 682.17M 679.10M 675.73M 672.52M 668.82M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
704.73M 701.78M 696.98M 692.25M 687.29M 685.56M 682.17M 679.10M 675.73M 672.52M 668.82M
Normalized Net Operating Profit after Tax (NOPAT)
-165 52 544 1,270 -300 153 704 1,403 -190 137 932
Normalized NOPAT Margin
-6.35% 1.40% 12.10% 20.78% -12.88% 3.84% 15.93% 21.74% -7.25% 3.51% 19.00%
Pre Tax Income Margin
-17.14% -8.71% 10.73% 21.89% -27.21% 2.21% 17.75% 27.94% -14.13% -13.56% 17.49%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-6.66 -4.21 12.76 21.27 -8.59 2.47 22.78 35.69 -7.04 -10.52 24.83
NOPAT to Interest Expense
-2.86 -1.89 11.83 18.14 -4.88 -1.22 19.02 25.83 -4.58 2.75 23.73
EBIT Less CapEx to Interest Expense
-9.45 -16.76 5.54 17.82 -13.26 -3.57 17.56 31.15 -13.87 -20.17 20.33
NOPAT Less CapEx to Interest Expense
-5.65 -14.43 4.61 14.69 -9.55 -7.25 13.80 21.29 -11.41 -6.90 19.23
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
45.93% 58.77% 77.76% 49.34% 63.93% 254.30% 247.74% 229.04% 223.59% 195.20% 172.35%
Augmented Payout Ratio
128.99% 159.97% 210.16% 151.32% 195.19% 364.09% 336.89% 301.63% 286.87% 292.13% 262.03%

Financials Breakdown Chart

Key Financial Trends

Corteva’s latest quarter shows a sharp rebound in earnings and a much stronger operating result than the prior quarter, but cash flow and working capital remain the biggest watch items. In Q1 2026, revenue rose to $4.91 billion from $3.91 billion in Q4 2025, and operating income improved to $1.01 billion from $181 million. That said, operating cash flow was still negative because of a very large swing in operating assets and liabilities.

Over the last several years, Corteva has been a seasonal business with big swings quarter to quarter. Revenue and profitability are strongest in the middle of the year, while the first and fourth quarters often look weaker or even loss-making. The big picture trend is that the company has generally remained profitable on a full-year basis, but short-term working-capital movements can overwhelm reported earnings in any one quarter.

  • Q1 2026 revenue increased sharply to $4.91 billion, up from $3.91 billion in Q4 2025 and $4.42 billion in Q1 2025.
  • Gross profit improved to $2.53 billion in Q1 2026, supporting a much stronger operating result.
  • Operating income rebounded to $1.01 billion in Q1 2026 from a loss of $301 million in Q3 2025 and $181 million in Q4 2025.
  • Net income attributable to common shareholders turned positive at $720 million in Q1 2026, versus a loss of $552 million in Q4 2025.
  • Cash and equivalents rose to $1.96 billion at the end of Q1 2026 from $3.11 billion at year-end 2024, and the company still held substantial current assets overall.
  • Book equity remained solid, with total common equity of $24.36 billion in Q1 2026.
  • Quarterly performance remains highly seasonal, with stronger mid-year quarters and weaker first/fourth quarters across the past few years.
  • Debt levels are manageable relative to equity, but Corteva continues to rely on both short-term and long-term borrowing to support operations and shareholder returns.
  • The balance sheet carries a large amount of goodwill and intangible assets, which means a meaningful portion of equity is tied to acquisition-related assets rather than hard assets.
  • Operating cash flow was negative $5.78 billion in Q1 2026, driven by a $8.31 billion negative swing in operating assets and liabilities.
  • Q1 2026 included $92 million of restructuring charges, suggesting ongoing cost actions and some execution pressure.
  • Other income/expense was unfavorable in Q1 2026 at negative $153 million, which reduced pretax income.
  • Inventory and receivables remain large on the balance sheet, which can create working-capital volatility and pressure cash conversion.

What stands out most for investors is that Corteva’s earnings power looks intact, but cash generation can be noisy. The latest quarter shows the company can still deliver strong profits when seasonality and operating conditions line up, yet the cash flow statement highlights how quickly working capital can reverse those gains. For retail investors, the key is to watch whether the company can sustain higher revenue and operating income while normalizing cash flow over the next few quarters.

06/12/26 03:51 AM ETAI Generated. May Contain Errors.

Corteva Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Corteva's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Corteva's net income appears to be on an upward trend, with a most recent value of $1.11 billion in 2025, falling from -$5.03 billion in 2018. The previous period was $919 million in 2024. See Corteva's forecast for analyst expectations on what's next for the company.

Corteva's total operating income in 2025 was $2.44 billion, based on the following breakdown:
  • Total Gross Profit: $8.23 billion
  • Total Operating Expenses: $5.79 billion

Over the last 7 years, Corteva's total revenue changed from $14.29 billion in 2018 to $17.40 billion in 2025, a change of 21.8%.

Corteva's total liabilities were at $18.46 billion at the end of 2025, a 9.9% increase from 2024, and a 72.5% decrease since 2018.

In the past 7 years, Corteva's cash and equivalents has ranged from $1.76 billion in 2019 to $4.54 billion in 2018, and is currently $4.52 billion as of their latest financial filing in 2025.

Over the last 7 years, Corteva's book value per share changed from 0.00 in 2018 to 35.73 in 2025, a change of 3,573.0%.



Financial statements for NYSE:CTVA last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners